A detailed history of Key F Inancial Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Key F Inancial Inc holds 23 shares of EXAS stock, worth $1,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 18 27.78%
Holding current value
$1,366
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$42.43 - $70.83 $212 - $354
5 Added 27.78%
23 $1,000
Q3 2021

Nov 01, 2021

BUY
$90.24 - $124.05 $1,624 - $2,232
18 New
18 $2,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.